Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

2.

Prevalence of potential drug interactions in Thai patients receiving simvastatin: The causality assessment of musculoskeletal adverse events induced by statin interaction.

Siriangkhawut M, Tansakul P, Uchaipichat V.

Saudi Pharm J. 2017 Sep;25(6):823-829. doi: 10.1016/j.jsps.2016.12.006. Epub 2016 Dec 23.

3.

Initial development and testing of an instrument for patient self-assessment of adverse drug reactions.

Jarernsiripornkul N, Chaipichit N, Pratipanawatr T, Uchaipichat V, Krska J.

Pharmacoepidemiol Drug Saf. 2016 Jan;25(1):54-63. doi: 10.1002/pds.3871. Epub 2015 Sep 9.

PMID:
26349635
4.

A qualitative study to explore how patients identify and assess symptoms as adverse drug reactions.

Chaipichit N, Krska J, Pratipanawatr T, Uchaipichat V, Jarernsiripornkul N.

Eur J Clin Pharmacol. 2014 May;70(5):607-15. doi: 10.1007/s00228-014-1653-6. Epub 2014 Feb 16.

PMID:
24531695
5.

The glucuronidation of R- and S-lorazepam: human liver microsomal kinetics, UDP-glucuronosyltransferase enzyme selectivity, and inhibition by drugs.

Uchaipichat V, Suthisisang C, Miners JO.

Drug Metab Dispos. 2013 Jun;41(6):1273-84. doi: 10.1124/dmd.113.051656. Epub 2013 Apr 3.

PMID:
23554428
6.

Patient reporting of suspected adverse drug reactions to antiepileptic drugs: factors affecting attribution accuracy.

Jarernsiripornkul N, Senacom P, Uchaipichat V, Chaipichit N, Krska J.

Epilepsy Behav. 2012 May;24(1):102-6. doi: 10.1016/j.yebeh.2012.03.023. Epub 2012 Apr 18.

PMID:
22520583
7.

Effects of ketamine on human UDP-glucuronosyltransferases in vitro predict potential drug-drug interactions arising from ketamine inhibition of codeine and morphine glucuronidation.

Uchaipichat V, Raungrut P, Chau N, Janchawee B, Evans AM, Miners JO.

Drug Metab Dispos. 2011 Aug;39(8):1324-8. doi: 10.1124/dmd.111.039727. Epub 2011 May 6.

PMID:
21551257
8.

In vitro-in vivo extrapolation of CYP2C8-catalyzed paclitaxel 6α-hydroxylation: effects of albumin on in vitro kinetic parameters and assessment of interindividual variability in predicted clearance.

Wattanachai N, Polasek TM, Heath TM, Uchaipichat V, Tassaneeyakul W, Tassaneeyakul W, Miners JO.

Eur J Clin Pharmacol. 2011 Aug;67(8):815-24. doi: 10.1007/s00228-011-1001-z. Epub 2011 Feb 9.

PMID:
21305272
9.

Formulation development of morphine sulfate sustained-release tablets and its bioequivalence study in healthy Thai volunteers.

Preechagoon D, Sumyai V, Chulavatnatol S, Kulvanich P, Tessiri T, Tontisirin K, Pongjanyakul T, Uchaipichat V, Aumpon S, Wongvipaporn C.

AAPS PharmSciTech. 2010 Sep;11(3):1449-55. doi: 10.1208/s12249-010-9518-5. Epub 2010 Sep 16.

10.

Effects of Andrographis paniculata and Orthosiphon stamineus extracts on the glucuronidation of 4-methylumbelliferone in human UGT isoforms.

Ismail S, Hanapi NA, Ab Halim MR, Uchaipichat V, Mackenzie PI.

Molecules. 2010 May 14;15(5):3578-92. doi: 10.3390/molecules15053578.

11.

In vitro-in vivo extrapolation predicts drug-drug interactions arising from inhibition of codeine glucuronidation by dextropropoxyphene, fluconazole, ketoconazole, and methadone in humans.

Raungrut P, Uchaipichat V, Elliot DJ, Janchawee B, Somogyi AA, Miners JO.

J Pharmacol Exp Ther. 2010 Aug;334(2):609-18. doi: 10.1124/jpet.110.167916. Epub 2010 May 18.

PMID:
20484152
12.
13.

Kinetic modeling of the interactions between 4-methylumbelliferone, 1-naphthol, and zidovudine glucuronidation by udp-glucuronosyltransferase 2B7 (UGT2B7) provides evidence for multiple substrate binding and effector sites.

Uchaipichat V, Galetin A, Houston JB, Mackenzie PI, Williams JA, Miners JO.

Mol Pharmacol. 2008 Oct;74(4):1152-62. doi: 10.1124/mol.108.048645. Epub 2008 Jul 22.

PMID:
18647858
14.

Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavir.

Boyd MA, Srasuebkul P, Ruxrungtham K, Mackenzie PI, Uchaipichat V, Stek M Jr, Lange JM, Phanuphak P, Cooper DA, Udomuksorn W, Miners JO.

Pharmacogenet Genomics. 2006 May;16(5):321-9.

PMID:
16609363
15.

Quantitative prediction of in vivo inhibitory interactions involving glucuronidated drugs from in vitro data: the effect of fluconazole on zidovudine glucuronidation.

Uchaipichat V, Winner LK, Mackenzie PI, Elliot DJ, Williams JA, Miners JO.

Br J Clin Pharmacol. 2006 Apr;61(4):427-39.

17.

Human udp-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid.

Uchaipichat V, Mackenzie PI, Guo XH, Gardner-Stephen D, Galetin A, Houston JB, Miners JO.

Drug Metab Dispos. 2004 Apr;32(4):413-23. Erratum in: Drug Metab Dispos. 2005 Dec;33(12):1925-6.

PMID:
15039294

Supplemental Content

Loading ...
Support Center